A Chatbot to Enhance COVID-19 Knowledge
Sponsor
Sun Yat-sen University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05689073
Collaborator
(none)
2,000
2
5
Study Details
Study Description
Brief Summary
The goal of this study is to explore whether a chatbot based on NLP techniques has better educational effect than printed booklets on knowledge of COVID-19 and its vaccination.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
2000 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Health Services Research
Official Title:
A Chatbot to Enhance COVID-19 Knowledge
Anticipated Study Start Date
:
Jan 17, 2023
Anticipated Primary Completion Date
:
Mar 17, 2023
Anticipated Study Completion Date
:
Jun 17, 2023
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Interactive Q&A chatbot
|
Device: chatbot
a chatbot based on NLP techniques
|
| Active Comparator: Educational booklet
|
Other: Printed educational booklet
a printed booklet
|
Outcome Measures
Primary Outcome Measures
- Knowledge level of the participants [Day 14]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
Individuals aged over 18 years who have been resident in the selected study district for more than six months; Willing to participate the study and provide informed consent.
Exclusion Criteria:
Having ocular, hearing or mental disorders precluding reading or telephone interview.
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Sun Yat-sen University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Yingfeng Zheng,
Professor,
Sun Yat-sen University
ClinicalTrials.gov Identifier:
NCT05689073
Other Study ID Numbers:
- 2021KYPJ182-2
First Posted:
Jan 18, 2023
Last Update Posted:
Jan 18, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: